| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, Ibu
1 company
Giles Richard Platford is President, Ibu at TKPHF. Giles Richard Platford's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $13.3M at current prices.
The TKPHF filings lean toward selling, a net 31,083 shares.
Giles Richard Platford has 3 Form 4 filings on record from April 2026 to August 2026, all as President, Ibu at Takeda Pharmaceutical (TKPHF), 2026.
The 3 reported transactions were 2 stock awards and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $532K.
The only open-market sale was 31,083 shares of TKPHF at an average $17.10 on August 10, 2026, about $532K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | TKPHF Takeda Pharmaceutical Company Limited | President, Ibu | Sell | 31,083 | $17.10 | $531,519.30 | -9.0% |